Fig. 3.

Overview of results for parameters reflecting PLT count (10⁹/L), PLT activation, PLT degranulation and coagulation before and at 5, 30, 60 and 150 min after starting HD treatment. Anti-clotting agent: low-molecular weight heparin; membrane characteristics: polysulphone. For comparison, the laboratory data of a reference group of 20 healthy controls (age 20–50 years) (REF) are also demonstrated [12, 15]. HD, haemodialysis; LMWH, low-molecular weight heparin; PF4, platelet factor 4 (kIU/L); PLT, platelet; TAT, thrombin antithrombin (µg/L)